Journals
Publish with us
Publishing partnerships
About us
Blog
Disease Markers
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Disease Markers
/
2022
/
Article
/
Tab 4
/
Research Article
Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma
Table 4
Comparison of EPIC scores after treatment (
).
Groups
Sexual function
Urinary function
Intestinal function
Hormonal function
Experimental group
45
Control group
45
13.695
20.025
12.802
11.218
<0.001
<0.001
<0.001
<0.001